Prevalence of Huntington's disease gene CAG repeat alleles in sporadic amyotrophic lateral sclerosis patients

References

• The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993;72:971–83.
   PubMed Web of Science ®Google Scholar
• Kenney C, Powell S, Jankovic J. Autopsy-proven Huntington's disease with 29 trinucleotide repeats. Mov Disord. 2007;22:127–30.
   PubMed Web of Science ®Google Scholar
• Eisen A, Mezei MM, Stewart HG, Fabros M, Gibson G, Andersen PM. SOD1 gene mutations in ALS patients from British Columbia, Canada: clinical features, neurophysiology and ethical issues in management. Amyotroph Lateral Scler. 2008;9:108–19.
   PubMed Web of Science ®Google Scholar
• Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, . TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008;40:572–4.
   PubMed Web of Science ®Google Scholar
• Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, . TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668–72.
   PubMed Web of Science ®Google Scholar
• Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, . Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205–8.
   PubMed Web of Science ®Google Scholar
• Vance C, Rogelj B, Hortobagyi T, de Vos KJ, Nishimura AL, Sreedharan J, . Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208–11.
   PubMed Web of Science ®Google Scholar
• Fuentealba RA, Udan M, Bell S, Wegorzewska I, Shao J, Diamond MI, . Interaction with polyglutamine aggregates reveals a Q/N-rich domain in TDP-43. J Biol Chem. 2010;285:26304–14.
   PubMed Web of Science ®Google Scholar
• Doi H, Koyano S, Suzuki Y, Nukina N, Kuroiwa Y. The RNA-binding protein FUS/TLS is a common aggregate-interacting protein in polyglutamine diseases. Neurosci Res. 2010;66:131–3.
   PubMed Web of Science ®Google Scholar
• Schwab C, Arai T, Hasegawa M, Yu S, McGeer PL. Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington's disease. J Neuropathol Exp Neurol. 2008;67:1159–65.
   PubMed Web of Science ®Google Scholar
• Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, . Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:223–6.
   PubMed Web of Science ®Google Scholar
• del Bo R, Tiloca C, Pensato V, Corrado L, Ratti A, Ticozzi N, . Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;82:1239–43.
   PubMed Web of Science ®Google Scholar
• Hortobagyi T, Troakes C, Nishimura AL, Vance C, van Swieten JC, Seelaar H, . Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders. Acta Neuropathol. 2011;121:519–27.
   PubMed Web of Science ®Google Scholar
• del Toro D, Alberch J, Lazaro-Dieguez F, Martin-Ibanez R, Xifro X, Egea G, . Mutant huntingtin impairs post-Golgi trafficking to lysosomes by delocalizing optineurin/Rab8 complex from the Golgi apparatus. Mol Biol Cell. 2009;20:1478–92.
   PubMed Web of Science ®Google Scholar
• Dejesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, . Expanded GGGGCC Hexanucleotide Repeat in Non-coding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011;72:245–56.
   PubMed Web of Science ®Google Scholar
• Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, . A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron. 2011;72:257–68.
   PubMed Web of Science ®Google Scholar
• Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, . Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069–75.
   PubMed Web of Science ®Google Scholar
• Lee T, Li YR, Ingre C, Weber M, Grehl T, Gredal O, . Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients. Hum Mol Genet. 2011;20: 1697–700.
   PubMed Web of Science ®Google Scholar
• van Damme P, Veldink JH, van Blitterswijk M, Corveleyn A, van Vught PW, Thijs V, . Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology. 2011;76:2066–72.
   PubMed Web of Science ®Google Scholar
• Perlis RH, Smoller JW, Mysore J, Sun M, Gillis T, Purcell S, . Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder. Am J Psychiatry. 2010;167:574–9.
   PubMedGoogle Scholar
• Warner JP, Barron LH, Brock DJ. A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Mol Cell Probes. 1993;7:235–9.
   PubMedGoogle Scholar
• Andresen JM, Gayan J, Djousse L, Roberts S, Brocklebank D, Cherny SS, . The relationship between CAG repeat length and age of onset differs for Huntington's disease patients with juvenile onset or adult onset. Ann Hum Genet. 2007;71:295–301.
   PubMedGoogle Scholar
• Balch WE, Morimoto RI, Dillin A, Kelly JW. Adapting proteostasis for disease intervention. Science. 2008;319: 916–9.
   PubMed Web of Science ®Google Scholar
• Gidalevitz T, Ben-Zvi A, Ho KH, Brignull HR, Morimoto RI. Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science. 2006;311:1471–4.
   PubMed Web of Science ®Google Scholar
• Rubio A, Steinberg K, Figlewicz DA, MacDonald ME, Greenamyre T, Hamill R, . Coexistence of Huntington's disease and familial amyotrophic lateral sclerosis: case presentation. Acta Neuropathol. 1996;92:421–7.
   PubMedGoogle Scholar
• Sadeghian H, O'Suilleabhain PE, Battiste J, Elliott JL, Trivedi JR. Huntington chorea presenting with motor neuron disease. Arch Neurol. 2011;68:650–2.
   PubMedGoogle Scholar
• Gamez J, Corbera-Bellalta M, Mila M, Lopez-Lisbona R, Boluda S, Ferrer I. Chorea-ballism associated with familial amyotrophic lateral sclerosis: a clinical, genetic, and neuropathological study. Mov Disord. 2008;23:434–8.
   PubMed Web of Science ®Google Scholar
• Pradat PF, Salachas F, Lacomblez L, Patte N, Leforestier N, Gaura V, . Association of chorea and motor neuron disease. Mov Disord. 2002;17:419–20.
   PubMed Web of Science ®Google Scholar
• Lee T, Li YR, Chesi A, Hart MP, Ramos D, Jethava N, . Evaluating the prevalence of polyglutamine repeat expansions in amyotrophic lateral sclerosis. Neurology. 2011;76: 2062–5.
   PubMed Web of Science ®Google Scholar
• Ross OA, Rutherford NJ, Baker M, Soto-Ortolaza AI, Carrasquillo MM, de Jesus-Hernandez M, . Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet. 2011;20:3207–12.
   PubMed Web of Science ®Google Scholar